Jazz Pharmaceuticals plc has acquired EUSA Pharma. EUSA Pharma is now an international division of Jazz Pharmaceuticals and markets products around the world. The information about products on this web site is for non-U.S. residents only. For information on US products, including Erwinaze©, US residents should now visit JazzPharmaceuticals.com. Read the Press Release
EUSA Pharma focuses on in-licensing, developing and marketing late-stage oncology, oncology supportive care and critical care products. More about EUSA
There are more than 60 clinical studies evaluating the efficacy of Collatamp for the treatment or prevention of SSIs across a wide variety of surgical procedures including GI/colorectal, orthopaedic, cardiothoracic, vascular and others.
Our comprehensive global website for Caphosol provides a highly informative resource for oral mucositis and Caphosol. Simpler and faster, Caphosol.com provides much richer information, more supporting data and useful handouts with real stories from patients who have experienced oral mucositis.
If you or someone you know is suffering oral mucositis then Caphosol.com may be what you're looking for.
A refreshingly innovative approach to simplifying the "science" and treatment of oral mucositis (OM is a particularly nasty and painful side effect of some cancer therapies).
MouthsMadeGood.com is available in 14 languages and is our most sought after internet resource.
Our All about ALL website offers simple, easy and accurate information and advice about Acute Lymphoblastic Leukaemia (ALL).
Whether you are an adult patient, a child patient or a parent/carer of a child with Acute Lymphoblastic Leukaemia, this site is designed with you in mind.
The product information on this site is for residents outside of the US. In the US, Jazz Pharmaceuticals now markets Erwinaze©, ProstaScint©, Quadramet©, and Caphosol©. Please visit JazzPharmaceuticals.com for more information.
Additional resources and information are available.
Click here to view
Specialized information is available here. If you are not an "HcP" you should not access this information.